Bellevue, United States
Viome, founded in 2016 and headquartered in the United States, is revolutionizing direct-to-consumer healthcare with its slogan: "The world's first and only at-home RNA test for precision nutrition." The company’s unique offering includes the only healthcare test that analyzes both microbial and human gene expressions using mRNA, deploying technology exclusively licensed from Los Alamos National Lab.
The precision behind Viome's approach enables personalized, actionable health recommendations, positioning it as a key player in the burgeoning personalized health sector. Their innovative tests serve as ongoing health companions rather than one-time diagnostics, allowing customers to track and adapt to changes in their health over time.
Backed by a robust team of scientists and engineers, Viome recently secured a $25.00M Series D investment with contributors such as Khosla Ventures, West River Group, Bold Capital, and Marc Benioff, reinforcing confidence in its business model and growth trajectory.
VAY